NRXS
NeurAxis, Inc.
Price Chart
Latest Quote
$7.00
-0.16 (-2.23%)
Current Price
| Previous Close | $7.16 |
| Open | $7.00 |
| Day High | $7.30 |
| Day Low | $7.00 |
| Volume | 62,615 |
Stock Information
| Shares Outstanding | 12.38M |
| Total Debt | $354K |
| Cash Equivalents | $7.08M |
| Revenue | $4.28M |
| Net Income | $-8.07M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $86.69M |
| EPS (TTM) | $-0.80 |
| Exchange | ASE |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $81.95M |
| Sales | $4.28M |
| Income | $-8.07M |
| Book/sh | $0.50 |
| Cash/sh | $0.57 |
| Employees | 24 |
Financial Ratios
| Quick Ratio | 2.65 |
| Current Ratio | 2.89 |
| Debt/Eq | 6.15 |
Returns & Margins
| ROA | -77.11% |
| ROE | -242.53% |
| Gross Margin | 85.01% |
| Operating Margin | -108.26% |
| Profit Margin | -170.11% |
Ownership
| Insider Ownership | 21.43% |
| Institutional Ownership | 22.75% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -116.67 |
| P/S | 20.25 |
| P/B | 13.94 |
Analyst Data
| Recommendation | none |
| Target Price | $11.00 |
Technical Indicators
| SMA20 | $7.00 |
| SMA50 | $7.43 |
| SMA200 | $4.97 |
| RSI | 49.76 |
| ATR | 0.3650 |
| Shares Float | 8.10M |
| Short Float | 5.39% |
| Short Ratio | 3.15 |
| Volatility | 1.41 |
| Rel Volume | 0.51 |
Performance History
| Week | +2.94% |
| Month | -5.79% |
| Quarter | -4.24% |
| 6 Months | +143.06% |
| YTD | +56.95% |
| Year | +175.59% |
| 10 Years | +16.67% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $7.00 | 62,615 |
| 2026-06-22 | $7.16 | 79,700 |
| 2026-06-18 | $7.15 | 164,500 |
| 2026-06-17 | $6.71 | 106,100 |
| 2026-06-16 | $6.71 | 69,000 |
| 2026-06-15 | $6.80 | 81,100 |
| 2026-06-12 | $6.70 | 65,800 |
| 2026-06-11 | $6.89 | 155,800 |
| 2026-06-10 | $6.80 | 61,800 |
| 2026-06-09 | $6.80 | 131,800 |
| 2026-06-08 | $6.67 | 97,100 |
| 2026-06-05 | $6.84 | 147,800 |
| 2026-06-04 | $7.27 | 95,500 |
| 2026-06-03 | $7.07 | 186,100 |
| 2026-06-02 | $7.01 | 239,400 |
| 2026-06-01 | $7.34 | 252,000 |
| 2026-05-29 | $7.41 | 73,100 |
| 2026-05-28 | $7.29 | 138,300 |
| 2026-05-27 | $7.45 | 146,200 |
| 2026-05-26 | $7.00 | 118,100 |
About NeurAxis, Inc.
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
đ° Latest News
NeurAxis (NRXS) Climbs on Reimbursement and Guideline Momentum
Insider Monkey âĸ 2026-05-18T12:47:53Z
NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y
Zacks âĸ 2026-05-15T16:23:00Z
Neuraxis Inc (NRXS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Coverage Challenges
GuruFocus.com âĸ 2026-05-12T23:01:58ZThe Zacks Analyst Blog Highlights Alphabet, Walmart, Micron Technology and NeurAxis
Zacks âĸ 2026-05-05T10:34:00Z
Top Stock Reports for Alphabet, Walmart & Micron
Zacks âĸ 2026-05-04T20:11:00Z
NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth
Zacks âĸ 2026-03-24T15:09:00Z
Neuraxis Inc (NRXS) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Operational Challenges
GuruFocus.com âĸ 2026-03-19T19:02:29ZNeurAxis, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-19T12:30:00Z
Top Stock Reports for Meta, Bank of America & Procter & Gamble
Zacks âĸ 2026-01-05T21:34:00Z
NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth
Zacks âĸ 2025-11-17T17:17:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $562,916 | $362,002 | $303,345 | $297,060 |
| Cost Of Revenue | $562,916 | $362,002 | $303,345 | $297,060 |
| Total Revenue | $3,569,282 | $2,685,925 | $2,460,049 | $2,684,735 |
| Operating Revenue | $3,569,282 | $2,685,925 | $2,460,049 | $2,684,735 |
| Expenses | ||||
| Interest Expense | $73,969 | $300,715 | $5,358,038 | $417,601 |
| Total Expenses | $11,399,190 | $9,842,742 | $9,124,544 | $6,056,973 |
| Other Income Expense | $133,562 | $-553,145 | $-2,601,378 | $1,331,994 |
| Other Non Operating Income Expenses | $141,196 | $-552,204 | $4,778 | $11,956 |
| Net Non Operating Interest Income Expense | $-104,209 | $-531,539 | $-5,360,810 | $-2,739,817 |
| Total Other Finance Cost | $30,240 | $230,824 | $2,772 | $2,322,216 |
| Interest Expense Non Operating | $73,969 | $300,715 | $5,358,038 | $417,601 |
| Operating Expense | $10,836,274 | $9,480,740 | $8,821,199 | $5,759,913 |
| Selling And Marketing Expense | $2,279,974 | $1,468,884 | $323,569 | $410,883 |
| General And Administrative Expense | $8,062,689 | $7,578,242 | $8,328,315 | $5,123,420 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-7,800,555 | $-8,241,501 | $-14,626,683 | $-4,780,061 |
| Net Interest Income | $-104,209 | $-531,539 | $-5,360,810 | $-2,739,817 |
| Normalized Income | $-7,792,921 | $-8,240,560 | $-12,020,527 | $-6,100,099 |
| Net Income From Continuing And Discontinued Operation | $-7,800,555 | $-8,241,501 | $-14,626,683 | $-4,780,061 |
| Total Operating Income As Reported | $-7,829,908 | $-7,156,817 | $-6,664,495 | $-3,372,238 |
| Net Income Common Stockholders | $-8,615,152 | $-8,452,769 | $-14,626,683 | $-5,544,954 |
| Net Income | $-7,800,555 | $-8,241,501 | $-14,626,683 | $-4,780,061 |
| Net Income Including Noncontrolling Interests | $-7,800,555 | $-8,241,501 | $-14,626,683 | $-4,780,061 |
| Net Income Continuous Operations | $-7,800,555 | $-8,241,501 | $-14,626,683 | $-4,780,061 |
| Pretax Income | $-7,800,555 | $-8,241,501 | $-14,626,683 | $-4,780,061 |
| Special Income Charges | $0 | $0 | $-3,649,561 | $0 |
| Operating Income | $-7,829,908 | $-7,156,817 | $-6,664,495 | $-3,372,238 |
| Gross Profit | $3,006,366 | $2,323,923 | $2,156,704 | $2,387,675 |
| Interest Income | - | - | - | - |
| Interest Income Non Operating | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-0.95 | $-1.22 | $-2.25 | $-0.90 |
| Basic EPS | $-0.95 | $-1.22 | $-2.25 | $-0.90 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-7,659,451 | $-7,902,014 | $-6,621,764 | $-5,645,365 |
| Total Unusual Items | $-7,634 | $-941 | $-2,606,156 | $1,320,038 |
| Total Unusual Items Excluding Goodwill | $-7,634 | $-941 | $-2,606,156 | $1,320,038 |
| Reconciled Depreciation | $59,501 | $37,831 | $40,725 | $37,133 |
| EBITDA (Bullshit earnings) | $-7,667,085 | $-7,902,955 | $-9,227,920 | $-4,325,327 |
| EBIT | $-7,726,586 | $-7,940,786 | $-9,268,645 | $-4,362,460 |
| Diluted Average Shares | $9,083,399 | $6,918,887 | $6,508,897 | $8,412,245 |
| Basic Average Shares | $9,083,399 | $6,918,887 | $6,508,897 | $6,139,973 |
| Diluted NI Availto Com Stockholders | $-8,615,152 | $-8,452,769 | $-14,626,683 | $-5,544,954 |
| Preferred Stock Dividends | $814,597 | $211,268 | - | $764,893 |
| Gain On Sale Of Security | $-7,634 | $-941 | $1,043,405 | $1,320,038 |
| Research And Development | $493,611 | $433,614 | $169,315 | $225,610 |
| Selling General And Administration | $10,342,663 | $9,047,126 | $8,651,884 | $5,534,303 |
| Other Gand A | $8,062,689 | $7,578,242 | $8,328,315 | $5,123,420 |
| Other Special Charges | - | - | $3,649,561 | - |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,124,594 | $1,971,160 | $-1,511,314 | $-5,651,171 |
| Total Assets | $6,404,036 | $4,757,572 | $509,498 | $1,480,644 |
| Total Non Current Assets | $670,846 | $491,389 | $266,888 | $1,003,687 |
| Non Current Prepaid Assets | $35,075 | $20,163 | $0 | - |
| Non Current Deferred Assets | $23,864 | $0 | $0 | $736,736 |
| Goodwill And Other Intangible Assets | $274,778 | $96,588 | $108,073 | $77,558 |
| Other Intangible Assets | $274,778 | $96,588 | $108,073 | $77,558 |
| Current Assets | $5,733,190 | $4,266,183 | $242,610 | $476,957 |
| Other Current Assets | $70,594 | $54,505 | $69,663 | $726 |
| Prepaid Assets | $244,689 | $225,862 | - | - |
| Inventory | $257,132 | $44,328 | $21,220 | $48,133 |
| Receivables | $195,703 | $244,618 | $73,167 | $174,399 |
| Accounts Receivable | $195,703 | $244,618 | $73,167 | $174,399 |
| Allowance For Doubtful Accounts Receivable | $-7,326 | $-5,000 | $-11,993 | - |
| Gross Accounts Receivable | $203,029 | $249,618 | $85,160 | - |
| Cash Cash Equivalents And Short Term Investments | $4,965,072 | $3,696,870 | $78,560 | $253,699 |
| Cash And Cash Equivalents | $4,965,072 | $3,696,870 | $78,560 | $253,699 |
| Cash Financial | $4,965,072 | $3,696,870 | $78,560 | - |
| Debt | ||||
| Total Debt | $416,611 | $473,405 | $224,260 | $598,821 |
| Long Term Debt And Capital Lease Obligation | $202,566 | $256,499 | $27,071 | $76,199 |
| Current Debt And Capital Lease Obligation | $214,045 | $216,906 | $197,189 | $522,622 |
| Current Debt | $148,293 | $154,152 | $148,062 | $489,227 |
| Net Debt | - | - | $69,502 | $235,528 |
| Other Current Borrowings | - | - | - | $228,342 |
| Long Term Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,004,664 | $2,689,824 | $1,912,739 | $7,054,257 |
| Total Non Current Liabilities Net Minority Interest | $212,565 | $256,499 | $27,071 | $76,199 |
| Other Non Current Liabilities | $9,999 | - | - | - |
| Current Liabilities | $2,792,099 | $2,433,325 | $1,885,668 | $6,978,058 |
| Other Current Liabilities | $16,800 | $9,166 | $8,225 | $3,970,084 |
| Current Deferred Liabilities | $28,660 | $32,527 | $74,947 | $59,174 |
| Current Notes Payable | $148,293 | $154,152 | $148,062 | $260,885 |
| Payables And Accrued Expenses | $479,918 | $913,409 | $1,271,830 | $1,886,620 |
| Interest Payable | $66,648 | $66,648 | $66,648 | $205,468 |
| Payables | $139,365 | $596,946 | $1,204,219 | $1,592,116 |
| Accounts Payable | $139,365 | $596,946 | $1,204,219 | $1,592,116 |
| Total Tax Payable | - | - | - | $777 |
| Equity | ||||
| Common Stock Equity | $3,395,575 | $2,063,467 | $-1,403,241 | $-5,574,235 |
| Preferred Stock Equity | $3,797 | $4,281 | - | $622 |
| Total Equity Gross Minority Interest | $3,399,372 | $2,067,748 | $-1,403,241 | $-5,573,613 |
| Stockholders Equity | $3,399,372 | $2,067,748 | $-1,403,241 | $-5,573,613 |
| Retained Earnings | $-64,600,167 | $-56,799,612 | $-48,558,111 | $-33,931,428 |
| Other | ||||
| Ordinary Shares Number | $10,652,812 | $6,990,227 | $6,508,897 | $6,042,090 |
| Share Issued | $10,652,812 | $6,990,227 | $6,508,897 | $6,042,090 |
| Tangible Book Value | $3,120,797 | $1,966,879 | $-1,511,314 | $-5,651,793 |
| Invested Capital | $3,543,868 | $2,217,619 | $-1,255,179 | $-5,085,008 |
| Working Capital | $2,941,091 | $1,832,858 | $-1,643,058 | $-6,501,101 |
| Capital Lease Obligations | $268,318 | $319,253 | $76,198 | $109,594 |
| Total Capitalization | $3,399,372 | $2,067,748 | $-1,403,241 | $-5,573,613 |
| Additional Paid In Capital | $67,985,089 | $58,856,089 | $47,148,361 | $28,355,230 |
| Capital Stock | $14,450 | $11,271 | $6,509 | $2,585 |
| Common Stock | $10,653 | $6,990 | $6,509 | $1,963 |
| Preferred Stock | $3,797 | $4,281 | $0 | $622 |
| Long Term Capital Lease Obligation | $202,566 | $256,499 | $27,071 | $76,199 |
| Current Deferred Revenue | $28,660 | $32,527 | $74,947 | $59,174 |
| Current Capital Lease Obligation | $65,752 | $62,754 | $49,127 | $33,395 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,359,993 | $1,261,317 | $333,477 | $539,558 |
| Current Provisions | $692,683 | - | - | - |
| Current Accrued Expenses | $340,553 | $316,463 | $67,611 | $294,504 |
| Net PPE | $337,129 | $374,638 | $158,815 | $189,393 |
| Accumulated Depreciation | $-306,901 | $-374,420 | $-348,074 | $-317,834 |
| Gross PPE | $644,030 | $749,058 | $506,889 | $507,227 |
| Leases | $0 | $21,064 | $21,064 | $21,064 |
| Machinery Furniture Equipment | $382,465 | $443,338 | $415,562 | $384,781 |
| Buildings And Improvements | $261,565 | $284,656 | $70,263 | $101,382 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-34,524 | $-4,454 | - | - |
| Other Inventories | $291,656 | $48,782 | - | - |
| Other Properties | - | - | $70,263 | $101,382 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-6,563,993 | $-6,126,040 | $-6,765,759 | $-2,359,209 |
| Operating Activities | ||||
| Operating Cash Flow | $-6,432,843 | $-6,098,264 | $-6,693,978 | $-2,298,004 |
| Cash Flow From Continuing Operating Activities | $-6,432,843 | $-6,098,264 | $-6,693,978 | $-2,298,004 |
| Operating Gains Losses | $15,512 | $158,686 | $2,606,156 | $-1,320,038 |
| Investing Activities | ||||
| Capital Expenditure | $-131,150 | $-27,776 | $-71,781 | $-61,205 |
| Investing Cash Flow | $-131,150 | $-27,776 | $-71,781 | $-61,205 |
| Cash Flow From Continuing Investing Activities | $-131,150 | $-27,776 | $-71,781 | $-61,205 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $7,728,423 | $5,253,663 | $4,847,457 | $0 |
| Financing Cash Flow | $7,832,195 | $9,744,350 | $6,590,620 | $2,292,050 |
| Cash Flow From Continuing Financing Activities | $7,832,195 | $9,744,350 | $6,570,620 | $2,292,050 |
| Net Other Financing Charges | $-712,669 | $-194,502 | $-532,000 | $-866,736 |
| Net Preferred Stock Issuance | $0 | $5,253,663 | $0 | $0 |
| Preferred Stock Issuance | $0 | $5,253,663 | $0 | $0 |
| Net Common Stock Issuance | $7,728,423 | $0 | $4,847,457 | $0 |
| Common Stock Issuance | $7,728,423 | $0 | $4,847,457 | $0 |
| Other | ||||
| Repayment Of Debt | $-281,751 | $-275,994 | $-3,553,765 | $-163,214 |
| Issuance Of Debt | $0 | $4,935,003 | $5,619,831 | $3,322,000 |
| Interest Paid Supplemental Data | $11,854 | $33,830 | $214,562 | $202,781 |
| Income Tax Paid Supplemental Data | $13,140 | $10,164 | $0 | $0 |
| End Cash Position | $4,965,072 | $3,696,870 | $78,560 | $253,699 |
| Beginning Cash Position | $3,696,870 | $78,560 | $253,699 | $320,858 |
| Changes In Cash | $1,268,202 | $3,618,310 | $-175,139 | $-67,159 |
| Proceeds From Stock Option Exercised | $1,098,192 | $26,180 | $209,097 | $0 |
| Net Issuance Payments Of Debt | $-281,751 | $4,659,009 | $2,066,066 | $3,158,786 |
| Net Short Term Debt Issuance | $-281,751 | $4,659,009 | $2,066,066 | $3,158,786 |
| Short Term Debt Payments | $-281,751 | $-275,994 | $-3,553,765 | $-163,214 |
| Short Term Debt Issuance | $0 | $4,935,003 | $5,619,831 | $3,322,000 |
| Net Intangibles Purchase And Sale | $-100,000 | $0 | $-41,000 | $-59,815 |
| Purchase Of Intangibles | $-100,000 | $0 | $-41,000 | $-59,815 |
| Net PPE Purchase And Sale | $-31,150 | $-27,776 | $-30,781 | $-1,390 |
| Purchase Of PPE | $-31,150 | $-27,776 | $-30,781 | $-1,390 |
| Change In Working Capital | $610,119 | $141,398 | $-665,747 | $1,270,394 |
| Change In Other Current Liabilities | $-55,848 | $-3,414 | $-33,396 | $-27,582 |
| Change In Payables And Accrued Expense | $625,144 | $342,420 | $-682,051 | $1,380,751 |
| Change In Accrued Expense | $1,082,727 | $949,693 | $-294,154 | $272,425 |
| Change In Payable | $-457,583 | $-607,273 | $-387,897 | $1,108,326 |
| Change In Account Payable | $-457,583 | $-607,273 | $-387,897 | $1,108,326 |
| Change In Prepaid Assets | $237,108 | $13,737 | $-53,164 | $4,781 |
| Change In Inventory | $-242,874 | $-32,500 | $26,913 | $-8,953 |
| Change In Receivables | $46,589 | $-178,845 | $75,951 | $-78,603 |
| Changes In Account Receivables | $46,589 | $-178,845 | $75,951 | $-78,603 |
| Other Non Cash Items | $53,332 | $389,286 | $5,176,290 | $2,447,744 |
| Stock Based Compensation | $596,852 | $1,404,187 | $750,000 | $27,319 |
| Provisionand Write Offof Assets | $32,396 | $11,849 | $25,281 | $19,505 |
| Depreciation Amortization Depletion | $59,501 | $37,831 | $40,725 | $37,133 |
| Depreciation And Amortization | $59,501 | $37,831 | $40,725 | $37,133 |
| Gain Loss On Investment Securities | $7,634 | $158,686 | $-1,043,405 | $-1,320,038 |
| Gain Loss On Sale Of PPE | $7,878 | $0 | - | - |
| Net Income From Continuing Operations | $-7,800,555 | $-8,241,501 | $-14,626,683 | $-4,780,061 |
| Change In Other Working Capital | - | - | $15,773 | $-10,163 |
| Net Long Term Debt Issuance | - | - | - | $-41,214 |
| Long Term Debt Payments | - | - | - | $-163,214 |
| Long Term Debt Issuance | - | - | - | $122,000 |
Fetched: 2026-06-19